HomeCompareCLSHX vs MRK

CLSHX vs MRK: Dividend Comparison 2026

CLSHX yields 16.14% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLSHX wins by $690.00 in total portfolio value
10 years
CLSHX
CLSHX
● Live price
16.14%
Share price
$12.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.5K
Annual income
$4,357.94
Full CLSHX calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CLSHX vs MRK

📍 CLSHX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLSHXMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLSHX + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLSHX pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSHX
Annual income on $10K today (after 15% tax)
$1,372.07/yr
After 10yr DRIP, annual income (after tax)
$3,704.25/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $4,624.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSHX + MRK for your $10,000?

CLSHX: 50%MRK: 50%
100% MRK50/50100% CLSHX
Portfolio after 10yr
$57.1K
Annual income
$7,078.04/yr
Blended yield
12.39%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CLSHX
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSHX buys
0
MRK buys
0
No recent congressional trades found for CLSHX or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLSHXMRK
Forward yield16.14%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$57.5K$56.8K
Annual income after 10y$4,357.94$9,798.13
Total dividends collected$29.0K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLSHX vs MRK ($10,000, DRIP)

YearCLSHX PortfolioCLSHX Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,314$1,614.21$11,206$366.19+$1.1KCLSHX
2$15,034$1,857.72$12,650$502.35+$2.4KCLSHX
3$18,206$2,119.65$14,407$694.19+$3.8KCLSHX
4$21,879$2,398.95$16,585$967.82+$5.3KCLSHX
5$26,105$2,694.37$19,342$1,363.89+$6.8KCLSHX
6$30,937$3,004.47$22,913$1,947.19+$8.0KCLSHX
7$36,430$3,327.63$27,662$2,823.89+$8.8KCLSHX
8$42,643$3,662.14$34,159$4,173.35+$8.5KCLSHX
9$49,634$4,006.19$43,337$6,308.80+$6.3KCLSHX
10$57,466$4,357.94$56,776$9,798.13+$690.00CLSHX

CLSHX vs MRK: Complete Analysis 2026

CLSHXStock

The investment seeks to limit the impact of large equity market declines; the secondary investment objective is growth of capital. The fund invests primarily in U.S. Treasury bills, individual equity securities, money market funds, exchange traded funds ("ETFs"), open-end mutual funds and closed-end funds that each invest primarily in equity securities (common stock and securities convertible into common stock). This group of ETFs and funds is referred to as "underlying funds." Equity securities, whether purchased directly or indirectly through underlying funds, are not restricted by issuer capitalization or country.

Full CLSHX Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CLSHX vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSHX vs SCHDCLSHX vs JEPICLSHX vs OCLSHX vs KOCLSHX vs MAINCLSHX vs JNJCLSHX vs ABBVCLSHX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.